Literature DB >> 2756458

Management of desmoid tumors.

J G McKinnon1, J P Neifeld, S Kay, G A Parker, W C Foster, W Lawrence.   

Abstract

Desmoid tumors are rare, being less than 0.03 per cent of all neoplasms. Because of scarcity of data and relatively small numbers of patients, optimal treatment remains controversial. In this report, our experience with 36 patients evaluated and treated from 1960 to 1987 is analyzed. The most common primary site was the wall of the chest (ten); eight tumors originated in the abdominal wall. Nine patients had a history of previous trauma, and eight of these were women. Thirty-two patients had wide local excision and two had amputations. Clear margins were obtained in only 22 patients despite an attempt at wide resection in all instances. With a mean follow-up period of 41 months and a median of 24 months, only one of 22 patients with negative histologic margins had recurrence of tumor. Among the 11 patients with positive margins, four received postoperative radiation therapy and two remain disease-free; of the seven remaining patients with positive margins, three had recurrences. One patient with unresectable disease was treated with tamoxifen with regression of tumor and remains alive 15 months later. These data suggest that the best treatment of desmoid tumors remains resection with a clear margin of normal tissue surrounding the tumor. Adjuvant radiotherapy did not appear to decrease the rate of local recurrence.

Entities:  

Mesh:

Year:  1989        PMID: 2756458

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  26 in total

1.  Full-thickness chest wall reconstruction using autologous tissue grafts after resection of recurrent desmoid tumor.

Authors:  Katsuyuki Asai; Kazuya Suzuki; Hiroshi Shimota; Yasushi Ito; Kazutoshi Asano; Teruhisa Kazui
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-06

2.  Desmoid tumour of the breast as a manifestation of Gardner's syndrome.

Authors:  Ashwin Rammohan; Jeremy J Wood
Journal:  Int J Surg Case Rep       Date:  2012-01-23

3.  Wide resection of the upper right hemithorax combined with amputation of the right arm for a recurrent desmoid tumor.

Authors:  Yasushi Sakamaki; Tetsuo Kido; Motoaki Yasukawa; Takashi Fujiwara; Katsuki Kuwae; Motomu Maeda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-08

4.  Extra-abdominal fibromatosis (desmoid tumor) arising in the infratemporal fossa: a case report.

Authors:  M Corsten; P Donald; J Boggan; A Gadre; R Gandour-Edwards; W Nemzek
Journal:  Skull Base Surg       Date:  1998

Review 5.  Radiation therapy for the treatment of benign vascular, skeletal and soft tissue diseases.

Authors:  A Montero Luis; R Hernanz de Lucas; A Hervás Morón; E Fernández Lizarbe; S Sancho García; C Vallejo Ocaña; A Polo Rubio; A Ramos Aguerri
Journal:  Clin Transl Oncol       Date:  2008-06       Impact factor: 3.405

6.  Desmoid tumor of the facet joint: a case report.

Authors:  Han Ga Wi Nam; Seung-Myung Moon; Sei-Woong Jeon; Hyung Sik Hwang
Journal:  Korean J Spine       Date:  2013-06-30

7.  Role of tumor-associated macrophages and angiogenesis in desmoid-type fibromatosis.

Authors:  Stefhanie Romero; Justyna Szafranska; Eliovel Cabrera; Allan Gonzalez; Ana Peiró; Jaume Llauger; Luis Ortega; Silvia Bague; Belén Canet; Inigo Espinosa; Jaime Prat
Journal:  Virchows Arch       Date:  2012-06-29       Impact factor: 4.064

8.  Fibromatosis of the breast in a 52-year-old man (2010: 10b).

Authors:  María Yolanda Torres Sousa; María Arias Ortega; María Librada Rozas Rodríguez; Cristina Maria Murillo Lázaro
Journal:  Eur Radiol       Date:  2010-12-02       Impact factor: 5.315

9.  Prognostic factors for desmoid tumor: a surgical series of 233 patients at a single institution.

Authors:  Wei-Gen Zeng; Zhi-Xiang Zhou; Jian-Wei Liang; Hui-Rong Hou; Zheng Wang; Hai-Tao Zhou; Xing-Mao Zhang; Jun-Jie Hu
Journal:  Tumour Biol       Date:  2014-05-02

Review 10.  Updates on abdominal desmoid tumors.

Authors:  Bernardino Rampone; Corrado Pedrazzani; Daniele Marrelli; Enrico Pinto; Franco Roviello
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.